Oaktree Specialty Lending
- Market cap
- 1.03B
- P/E (TTM)i
- 24.27
- P/Bi
- 0.74
- EPSi
- 0.39
- Div yieldi
- 13.22%
- 52W posi
- 54%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
- Total institutional ownership fell 3.1 percentage points.
Institutional ownership
- Held by institutions
- 49.03% -3.08pp
- Institutions
- 178 -2
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
14 filings tracked · 14 buys · 0 sells
| Name | Role | Stake |
|---|---|---|
| Craig Jacobson | Independent Director | 0.08% |
| Mathew Pendo | President | 0.06% |
| John Frank | Chairperson | 0.04% |
| Deborah Gero | Independent Director | 0.03% |
| Phyllis Caldwell | Independent Director | 0.03% |
| Armen Panossian | CEO & Chief Investment Officer | 0.03% |
| Bruce Zimmerman | Lead Independent Director | 0.02% |
| Christopher McKown | MD,CFO & Treasurer | 0.01% |
| Raghav Khanna | Managing Director & Co-Portfolio Manager | 0.01% |
| Ashley Pak | Chief Compliance Officer | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-11 | Armen Panossian | CEO & Chief Investment Officer | Open Market Acquisition | +1,700 | $12.69 |
| 2026-03-15 | Phyllis Caldwell | Independent Director | Open Market Acquisition | +2,500 | $10.77 |
| 2026-03-15 | Deborah Gero | Independent Director | Open Market Acquisition | +2,000 | $10.78 |
| 2025-09-14 | Phyllis Caldwell | Independent Director | Open Market Acquisition | +3,000 | $13.19–13.20 |
| 2025-06-29 | Deborah Gero | Independent Director | Open Market Acquisition | +2,500 | $13.70 |
| 2025-05-14 | Armen Panossian | CEO & Chief Investment Officer | Open Market Acquisition | +8,000 | $14.13 |
| 2025-05-06 | Phyllis Caldwell | Independent Director | Open Market Acquisition | +2,000 | $13.33 |
| 2025-05-05 | Craig Jacobson | Independent Director | Open Market Acquisition | +14,910 | $13.41 |
| 2025-02-24 | Phyllis Caldwell | Independent Director | Open Market Acquisition | +2,500 | $15.83 |
| 2025-02-23 | Raghav Khanna | Managing Director & Co-Portfolio Manager | Open Market Acquisition | +6,000 | $15.95 |
| 2025-02-23 | Mathew Pendo | President | Open Market Acquisition | +6,260 | $15.93 |
| 2024-09-19 | Phyllis Caldwell | Independent Director | Open Market Acquisition | +1,000 | $16.01–16.01 |
| 2024-08-12 | Phyllis Caldwell | Independent Director | Open Market Acquisition | +1,334 | $16.28–16.29 |
| 2024-02-11 | Phyllis Caldwell | Independent Director | Open Market Acquisition | +2,000 | $20.07 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 20:01:37 · For reference only, not investment advice and not tailored to your situation.